San Francisco, CA, United States of America

Christian Sieber

This inventor holds 1 USPTO granted patent. Top assignee: Pendulum Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Sieber. Retrieved from https://idiyas.com/inventor/christian-sieber-lja5aa0a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christian Sieber: Innovator in Microbial Therapeutics

Introduction

Christian Sieber is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of microbial therapeutics, focusing on methods and compositions that address gut dysbiosis. His innovative work aims to improve health outcomes through the therapeutic administration of specific microbial compositions.

Latest Patents

Christian Sieber holds a patent titled "Methods and compositions for microbial engraftment." This patent provides compositions and methods for the therapeutic administration of these compositions to treat comorbidities associated with gut dysbiosis. Additionally, it outlines methods for increasing the engraftment of administered microbes and includes techniques for stool sample collection. He has 1 patent to his name.

Career Highlights

Christian is currently employed at Pendulum Therapeutics, Inc., where he continues to develop innovative solutions in the realm of gut health. His work is pivotal in advancing the understanding and treatment of microbial imbalances in the human body.

Collaborations

Christian collaborates with notable professionals in his field, including John S Eid and Colleen Cutcliffe, who contribute to the innovative environment at Pendulum Therapeutics.

Conclusion

Christian Sieber's contributions to microbial therapeutics exemplify the impact of innovation in healthcare. His work not only addresses critical health issues but also paves the way for future advancements in the treatment of gut dysbiosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…